Forestalling Lidomageddon: Local Solutions to the Nationwide Shortage of Lidocaine

Main Article Content

Tanya Shenoy
University of Mississippi School of Medicine

Vinayak Nahar
University of Mississippi Medical Center

Melodie Goodwin
University of Mississippi Medical Center

Stephen E. Helms
University of Mississippi Medical Center

Robert T. Brodell
University of Mississippi Medical Center

William Black
University of Mississippi Medical Center

Keywords

lidocaine, bupivacaine, diphenhydramine, epinephrine, supply chain, local anesthesia

References

1. Morganroth PA, Gelfand JM, Jambusaria A, Margolis DJ, Miller CJ. A randomized, double-blind comparison of the total dose of 1.0% lidocaine with 1:100,000 epinephrine versus 0.5% lidocaine with 1:200,000 epinephrine required for effective local anesthesia during Mohs micrographic surgery for skin cancers. J Am Acad Dermatol. Mar 2009;60(3):444-52. doi:10.1016/j.jaad.2008.08.001

2. Bodie B, Brodell RT, Helms SE. Shortage of lidocaine with epinephrine: Causes and solutions. Journal of the American Academy of Dermatology. 2018;79(2):392-393. doi:10.1016/j.jaad.2018.02.035

3. Vent A, Surber C, Graf Johansen NT, et al. Buffered lidocaine 1%/epinephrine 1:100,000 with sodium bicarbonate (sodium hydrogen carbonate) in a 3:1 ratio is less painful than a 9:1 ratio: A double-blind, randomized, placebo-controlled, crossover trial. Journal of the American Academy of Dermatology. 2020;83(1):159-165. doi:10.1016/j.jaad.2019.09.088

4. Latham JL, Martin SN. Infiltrative anesthesia in office practice. Am Fam Physician. Jun 15 2014;89(12):956-62.

5. Grekin RC, Auletta MJ. Local anesthesia in dermatologic surgery. Journal of the American Academy of Dermatology. 1988/10/01/ 1988;19(4):599-614. doi:https://doi.org/10.1016/S0190-9622(88)70213-3

Article Sidebar

PDF
Published
Sep 12, 2022
DOI https://doi.org/10.25251/skin.6.5.17

Article Details

How to Cite
[1]
Shenoy, T., Nahar, V., Goodwin, M., Helms, S.E., Brodell, R.T. and Black, W. 2022. Forestalling Lidomageddon: Local Solutions to the Nationwide Shortage of Lidocaine. SKIN The Journal of Cutaneous Medicine. 6, 5 (Sep. 2022), 441–444. DOI:https://doi.org/10.25251/skin.6.5.17.
Issue
Vol. 6 No. 5 (2022)
Section
Short Communications
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.